Stempeutics receives Japan process patent for its novel stem cell drug

Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that it has been granted process patent from the Japan Patent Office for its novel stem-cell based drug Stempeucel.

[Read the full article here]

Comments are closed.